Clene Inc.

0.4941+0.0471+10.54%Vol 258.09K1Y Perf -74.31%
Oct 4th, 2023 16:00 DELAYED
BID0.4627 ASK0.5120
Open0.4700 Previous Close0.4470
Pre-Market- After-Market0.48
 - -  -0.01 -1.94%
Target Price
9.17 
Analyst Rating
Strong Buy 1.00
Potential %
1.76K 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
57/73/79 
Value Ranking
★+     43.80
Insiders Value % 3/6/12 mo.
79/87/89 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
85/90/91 
Income Ranking
 —    -
Price Range Ratio 52W %
4.64 
Earnings Rating
Market Cap63.44M 
Earnings Date
6th Nov 2023
Alpha-0.05 Standard Deviation0.29
Beta0.86 

Today's Price Range

0.46000.5126

52W Range

0.41402.14

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-1.18%
1 Month
-31.18%
3 Months
-41.87%
6 Months
-57.03%
1 Year
-74.31%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
CLNN0.49410.047110.54
AAPL173.661.26000.73
GOOG136.272.97002.23
MSFT318.965.56501.78
XOM111.50-4.3300-3.74
WFC38.970.30000.78
JNJ155.520.18000.12
FB196.640.99000.51
GE108.851.09001.01
JPM143.350.64000.45
Financial StrengthValueIndustryS&P 500US Markets
2.90
3.50
0.93
12.80
-7.90
Leverage Ratio -15.50
ProfitabilityValueIndustryS&P 500US Markets
215.10
-4 998.40
-4 784.70
-
-
RevenueValueIndustryS&P 500US Markets
239.00K
0.00
-
-
Earnings HistoryEstimateReportedSurprise %
Q02 2023-0.13-0.127.69
Q01 2023-0.16-0.156.25
Q04 2022-0.15-0.16-6.67
Q03 2022-0.23-0.1439.13
Q02 2022-0.21-0.22-4.76
Q01 2022-0.18-0.21-16.67
Q04 2021-0.18-0.19-5.56
Q03 2021-0.22-0.0386.36
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date6th Nov 2023
Estimated EPS Next Report-0.10
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume258.09K
Shares Outstanding128.40K
Shares Float68.14M
Trades Count851
Dollar Volume126.17K
Avg. Volume431.73K
Avg. Weekly Volume333.95K
Avg. Monthly Volume530.07K
Avg. Quarterly Volume431.18K

Clene Inc. (NASDAQ: CLNN) stock closed at 0.4941 per share at the end of the most recent trading day (a 10.54% change compared to the prior day closing price) with a volume of 258.09K shares and market capitalization of 63.44M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 74 people. Clene Inc. CEO is Robert Etherington.

The one-year performance of Clene Inc. stock is -74.31%, while year-to-date (YTD) performance is -50.59%. CLNN stock has a five-year performance of %. Its 52-week range is between 0.414 and 2.14, which gives CLNN stock a 52-week price range ratio of 4.64%

Clene Inc. currently has a PE ratio of -2.50, a price-to-book (PB) ratio of 114.28, a price-to-sale (PS) ratio of 321.23, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -49.94%, a ROC of -43.13% and a ROE of 1 085.74%. The company’s profit margin is -%, its EBITDA margin is -4 784.70%, and its revenue ttm is $239.00 Thousand , which makes it $0.00 revenue per share.

Of the last four earnings reports from Clene Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.10 for the next earnings report. Clene Inc.’s next earnings report date is 06th Nov 2023.

The consensus rating of Wall Street analysts for Clene Inc. is Strong Buy (1), with a target price of $9.17, which is +1 755.90% compared to the current price. The earnings rating for Clene Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Clene Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Clene Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 33.18, ATR14 : 0.06, CCI20 : -97.18, Chaikin Money Flow : -0.48, MACD : -0.06, Money Flow Index : 31.40, ROC : -17.22, RSI : 27.48, STOCH (14,3) : 14.61, STOCH RSI : 0.42, UO : 34.36, Williams %R : -85.39), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Clene Inc. in the last 12-months were: Alison Mosca (Buy at a value of $1 915 500), Etherington Robert Dee (Buy at a value of $20 250), John Henry Stevens (Buy at a value of $253 164), Jonathon Gay (Buy at a value of $84 500), Reed Neil Wilcox (Option Excercise at a value of $26 237), Robert Etherington (Buy at a value of $20 250), Stevens John Henry (Buy at a value of $253 164)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (100.00 %)
6 (100.00 %)
6 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Clene Inc.

Clene Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for neurodegenerative diseases..

CEO: Robert Etherington

Telephone: +1 801 676-9695

Address: 6550 South Millrock Drive, Salt Lake City 84121, UT, US

Number of employees: 74

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

55%45%

Bearish Bullish

54%46%

 

News

Stocktwits